Publications by authors named "Jeronimo Rodriguez-Cid"

Claim this Profile
E
Epidemiological description of genetic alterations and prognosis in Mexican patients with melanoma: a retrospective cohort.
Katia F Ávila-Fernández, Héctor Martínez-Said, Ivan R González-Espinoza, Rodrigo R Flores-Mariñelarena, Gabriela Juárez-Salazar

Cancer Treat Res Commun· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression patterns of estrogen and androgen receptors in NSCLC patients according to the PD-L1 profile.
Vianey Rodriguez-Lara, Gala Cortés-Ramírez, Itzel Amayrani Angeles-Torres, Jeronimo Rodriguez-Cid, Sally María Luisa Pedraza-Reyes

Front Immunol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase III KEYNOTE-789 Study of Pemetrexed and Platinum With or Without Pembrolizumab for Tyrosine Kinase Inhibitor‒Resistant, -Mutant, Metastatic Nonsquamous Non-Small Cell Lung Cancer.
James Chih-Hsin Yang, Dae Ho Lee, Jong-Seok Lee, Yun Fan, Filippo de Marinis

J Clin Oncol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estimation of the Clinical, Economic, and Social Burden of Stage IV Non-Small Cell Lung Cancer in Mexico.
Denisse Añorve Bailon, Javier Picó-Guzmán, Sergio Cifuentes, Rogelio Trejo, Jeronimo Rodríguez Cid

Pharmacoecon Open· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mutation profile in liquid biopsy tested by next generation sequencing in Mexican patients with non-small cell lung carcinoma and its impact on survival.
José Fabián Martínez-Herrera, Gisela Sánchez Domínguez, Juan J Juárez-Vignon Whaley, Sonia Carrasco-Cara Chards, Claudia López Vrátný

J Thorac Dis· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of sex and sex hormones in PD-L1 expression in NSCLC: clinical and therapeutic implications.
Vianey Rodriguez-Lara, Giovanny Soca-Chafre, Maria Rosa Avila-Costa, Juan Jose Juarez-Vignon Whaley, Jeronimo Rafael Rodriguez-Cid

Front Oncol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epirubicin, cisplatin plus ifosfamide versus standard chemotherapeutic regimens for advanced/unresectable primary thoracic sarcomas.
Jeronimo Rafael Rodriguez-Cid, Juan Jose Juarez-Vignon Whaley, Gisela Sánchez-Domínguez, Jordi Guzmán-Casta, Sonia Carrasco-CaraChards

J Cancer Res Clin Oncol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pembrolizumab Plus Chemotherapy in Squamous Non-Small-Cell Lung Cancer: 5-Year Update of the Phase III KEYNOTE-407 Study.
Silvia Novello, Dariusz M Kowalski, Alexander Luft, Mahmut Gümüş, David Vicente

J Clin Oncol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival prognostic factors in unresectable/advanced primary thoracic sarcomas.
Jerónimo R Rodriguez-Cid, Juan J Juarez-Vignon Whaley, Gisela Sánchez-Domínguez, Jordi Guzmán-Casta, Sonia Carrasco-CaraChards

J Thorac Dis· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Paraneoplastic Cerebellar Degeneration with Anti-CV2/CRMP5 Antibodies in Ovarian Cancer: Case Report and Review of the Literature.
Juan José Juárez-Vignon Whaley, Aurelio Carrera-Muiños, Karol Gema Hernandez-Gutierrez, Jerónimo Rafael Rodriguez-Cid, Maria Elisa Otero-Cerdeira

Case Rep Oncol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes With Pembrolizumab Plus Platinum-Based Chemotherapy for Patients With NSCLC and Stable Brain Metastases: Pooled Analysis of KEYNOTE-021, -189, and -407.
Steven F Powell, Delvys Rodríguez-Abreu, Corey J Langer, Ali Tafreshi, Luis Paz-Ares

J Thorac Oncol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A comparative study of immunotherapy as second-line treatment and beyond in patients with advanced non-small-cell lung carcinoma.
Jerónimo Rafael Rodríguez-Cid, Sonia Carrasco-Cara Chards, Iván Romarico González-Espinoza, Vanessa García-Montes, Julio César Garibay-Díaz

Lung Cancer Manag· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic factors for progression-free and overall survival in malignant pleural mesothelioma.
Jordi Guzmán-Casta, Sonia Carrasco-CaraChards, Jorge Guzmán-Huesca, Carla Paola Sánchez-Ríos, Rodrigo Riera-Sala

Thorac Cancer· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nivolumab and Ipilimumab as Maintenance Therapy in Extensive-Disease Small-Cell Lung Cancer: CheckMate 451.
Taofeek K Owonikoko, Keunchil Park, Ramaswamy Govindan, Neal Ready, Martin Reck

J Clin Oncol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Myoepithelial Carcinoma Arising in a Plasmacytoid Myoepithelioma of the Parotid Gland Synchronized with Melanoma: A Case Report and Review of the Literature.
Pamela Denisse Soberanis-Piña, Ricardo Fernández-Ferreira, Héctor Hugo Buerba-Vieregge, Edgar Varela-Santoyo, Jerónimo Rafael Rodriguez-Cid

Case Rep Oncol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Nivolumab Plus Ipilimumab versus Sunitinib in First-line Treatment of Patients with Advanced Sarcomatoid Renal Cell Carcinoma.
Nizar M Tannir, Sabina Signoretti, Toni K Choueiri, David F McDermott, Robert J Motzer, Jeronimo R Rodriguez-Cid

Clin Cancer Res· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brigatinib in -positive non-small cell lung cancer: real-world data in the Latin American population (Bri-world extend CLICaP).
David Heredia, Feliciano Barrón, Andrés F Cardona, Saul Campos, Jerónimo Rodriguez-Cid

Future Oncol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): a multicentre, randomised, open-label, phase 3 trial.
Paul Baas, Arnaud Scherpereel, Anna K Nowak, Nobukazu Fujimoto, Solange Peters

Lancet· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human skin biomarkers relationship to response to treatment with tyrosine kinase inhibitors in advanced EGFR-mutated lung adenocarcinoma.
Anahí Castañeda-Zárraga, Jerónimo Rafael Rodríguez-Cid, Rodrigo Rafael Flores-Mariñelarena, Héctor Trinidad-Bibiano, José Fabián Martínez-Herrera

Thorac Cancer· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Randomized, Placebo-Controlled Trial of Pembrolizumab Plus Chemotherapy in Patients With Metastatic Squamous NSCLC: Protocol-Specified Final Analysis of KEYNOTE-407.
Luis Paz-Ares, David Vicente, Ali Tafreshi, Andrew Robinson, Hector Soto Parra

J Thorac Oncol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Surgical care of thoracic malignancies during the COVID-19 pandemic in México: An expert consensus guideline from the Sociedad Mexicana de Oncología (SMeO) and the Sociedad Mexicana de Cirujanos Torácicos Generales (SMCTG).
Jose Corona-Cruz, Enrique Guzmán-de Alba, Marco Iñiguez-García, Raúl López-Saucedo, Carlos Olivares-Torres, Jeronimo Rodriguez-Cid

Thorac Cancer· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Evidence: Multicenter Efficacy and Toxicity Analysis of Nintedanib With Docetaxel as Second-Line Treatment in Mexican Patients With Advanced Lung Adenocarcinoma.
Jeronimo Rafael Rodríguez-Cid, Saul Campos-Gomez, Vanessa García-Montes, Manuel Magallanes-Maciel, Rodrigo Rafael Flores-Mariñelarena

JCO Glob Oncol· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[National Clinical Practice Guidelines for the management of non-small cell lung cancer in early, locally advanced and metastatic stages. Extended version].
Feliciano Barrón-Barrón, Enrique Guzmán-De Alba, Jorge Alatorre-Alexander, Fernando Aldaco-Sarvider, Yolanda Bautista-Aragón

Salud Publica Mex· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health-Related Quality of Life With Carboplatin-Paclitaxel or nab-Paclitaxel With or Without Pembrolizumab in Patients With Metastatic Squamous Non-Small-Cell Lung Cancer.
Julien Mazieres, Dariusz Kowalski, Alexander Luft, David Vicente, Ali Tafreshi

J Clin Oncol· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of estrogen receptor beta (ERβ) and its prognostic value in pleural mesothelioma.
Jeronimo Rafael Rodríguez-Cid, Orlando García-Acevedo, Javier Benjamin-Contreras, Diana Bonilla-Molina, Rodrigo Rafael Flores-Mariñelarena

J Thorac Dis· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis